A new report offering a comprehensive overview of Hidradenitis Suppurativa (HS), including its diagnosis, impact and treatment is now available for download from the Global Hidradenitis Suppurativa Atlas (GHiSA), an international non-profit organization working to raise awareness and knowledge about HS, with the International League of Dermatological Societies (ILDS).
The report is available for free download here. It is also available on the WHO Knowledge Action Portal on NCDs.
The report explores the gaps, barriers, and issues limiting a greater understanding of the global epidemiology of HS including a lack of consensus on HS prevalence worldwide, diagnostic delays, limited understanding of its prevalence by sex, race, and ethnicity, and insufficient data on comorbidities.
The report also covers emerging treatments and global efforts to improve management of HS. Report authors hope to guide policy makers and key stakeholders in allocating resources and improving healthcare for HS patients.
“Our Grand Challenges in Global Skin Health initiative addresses the significant burden of skin diseases worldwide by focusing on research, education, clinical application and support at local, national and international levels,” says ILDS President Henry W. Lim, MD, former Chair of the Department of Dermatology at Henry Ford Hospital and Senior Vice President for Academic Affairs at Henry Ford Health in Detroit, MI, in a news release. “We have already supported the development of Atlases for Psoriasis and Atopic Dermatitis, and are supporting the development of an Atlas for Vitiligo. We are now delighted to be working with GHiSA as it seeks to improve the lives of individuals affected by HS and we congratulate them on the publication of this important report.”
The report is available for free download here. It is also available on the WHO Knowledge Action Portal on NCDs.
